Alpad, Renalyn A.
HRN: 25-44-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2025
METRONIDAZOLE 500MG (TAB)
02/10/2025
02/16/2025
ORAL
500mg
TID
S/P NSVD, Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes